Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring
暂无分享,去创建一个
J. Pérez-Simón | M. Torrebadell | T. Caballero-Velázquez | C. Díaz-de-Heredia | Á. Molinos-Quintana | A. Faura | J. Pérez-Hurtado | Javier Delgado-Serrano | Berta González-Martínez | Antonio Pérez-Martínez | Víctor Galán-Gómez | Susana Rives | A. Alonso-Saladrigues | Blanca Herrero | M. Panesso | Concepción Pérez de Soto | Ana Castillo-Robleda